Concurrent hypereosinophilic syndrome and deep vein thrombosis after Pfizer‐BioNTech COVID‐19 vaccination: A case report
Abstract Herein, we report a case of eosinophilia syndrome and deep vein thrombosis presenting concurrently after the administration of the BNT162b2 mRNA‐based coronavirus disease 2019 (COVID‐19) vaccine. It is extremely rare to have both hypereosinophilic syndrome and deep vein thrombosis simultane...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-03-01
|
| Series: | Clinical Case Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ccr3.7001 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849329079390568448 |
|---|---|
| author | Shungo Yano Taiju Miyagami Takayuki Furusaka Nagamasa Kano Toshio Naito |
| author_facet | Shungo Yano Taiju Miyagami Takayuki Furusaka Nagamasa Kano Toshio Naito |
| author_sort | Shungo Yano |
| collection | DOAJ |
| description | Abstract Herein, we report a case of eosinophilia syndrome and deep vein thrombosis presenting concurrently after the administration of the BNT162b2 mRNA‐based coronavirus disease 2019 (COVID‐19) vaccine. It is extremely rare to have both hypereosinophilic syndrome and deep vein thrombosis simultaneously. Both are serious diseases and should be treated with caution. |
| format | Article |
| id | doaj-art-43f3b491e1de48aaa3d7a73acce40f05 |
| institution | Kabale University |
| issn | 2050-0904 |
| language | English |
| publishDate | 2023-03-01 |
| publisher | Wiley |
| record_format | Article |
| series | Clinical Case Reports |
| spelling | doaj-art-43f3b491e1de48aaa3d7a73acce40f052025-08-20T03:47:23ZengWileyClinical Case Reports2050-09042023-03-01113n/an/a10.1002/ccr3.7001Concurrent hypereosinophilic syndrome and deep vein thrombosis after Pfizer‐BioNTech COVID‐19 vaccination: A case reportShungo Yano0Taiju Miyagami1Takayuki Furusaka2Nagamasa Kano3Toshio Naito4Department of General Medicine Juntendo University Faculty of Medicine Tokyo JapanDepartment of General Medicine Juntendo University Faculty of Medicine Tokyo JapanDepartment of General Medicine Juntendo University Faculty of Medicine Tokyo JapanDepartment of General Medicine Juntendo University Faculty of Medicine Tokyo JapanDepartment of General Medicine Juntendo University Faculty of Medicine Tokyo JapanAbstract Herein, we report a case of eosinophilia syndrome and deep vein thrombosis presenting concurrently after the administration of the BNT162b2 mRNA‐based coronavirus disease 2019 (COVID‐19) vaccine. It is extremely rare to have both hypereosinophilic syndrome and deep vein thrombosis simultaneously. Both are serious diseases and should be treated with caution.https://doi.org/10.1002/ccr3.7001adverse events following immunizationCOVID‐19case reportdeep vein thrombosishypereosinophilic syndrome |
| spellingShingle | Shungo Yano Taiju Miyagami Takayuki Furusaka Nagamasa Kano Toshio Naito Concurrent hypereosinophilic syndrome and deep vein thrombosis after Pfizer‐BioNTech COVID‐19 vaccination: A case report Clinical Case Reports adverse events following immunization COVID‐19 case report deep vein thrombosis hypereosinophilic syndrome |
| title | Concurrent hypereosinophilic syndrome and deep vein thrombosis after Pfizer‐BioNTech COVID‐19 vaccination: A case report |
| title_full | Concurrent hypereosinophilic syndrome and deep vein thrombosis after Pfizer‐BioNTech COVID‐19 vaccination: A case report |
| title_fullStr | Concurrent hypereosinophilic syndrome and deep vein thrombosis after Pfizer‐BioNTech COVID‐19 vaccination: A case report |
| title_full_unstemmed | Concurrent hypereosinophilic syndrome and deep vein thrombosis after Pfizer‐BioNTech COVID‐19 vaccination: A case report |
| title_short | Concurrent hypereosinophilic syndrome and deep vein thrombosis after Pfizer‐BioNTech COVID‐19 vaccination: A case report |
| title_sort | concurrent hypereosinophilic syndrome and deep vein thrombosis after pfizer biontech covid 19 vaccination a case report |
| topic | adverse events following immunization COVID‐19 case report deep vein thrombosis hypereosinophilic syndrome |
| url | https://doi.org/10.1002/ccr3.7001 |
| work_keys_str_mv | AT shungoyano concurrenthypereosinophilicsyndromeanddeepveinthrombosisafterpfizerbiontechcovid19vaccinationacasereport AT taijumiyagami concurrenthypereosinophilicsyndromeanddeepveinthrombosisafterpfizerbiontechcovid19vaccinationacasereport AT takayukifurusaka concurrenthypereosinophilicsyndromeanddeepveinthrombosisafterpfizerbiontechcovid19vaccinationacasereport AT nagamasakano concurrenthypereosinophilicsyndromeanddeepveinthrombosisafterpfizerbiontechcovid19vaccinationacasereport AT toshionaito concurrenthypereosinophilicsyndromeanddeepveinthrombosisafterpfizerbiontechcovid19vaccinationacasereport |